RT Journal Article
SR Electronic
T1 Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): a retrospective observational analysis of 193 confirmed cases in Thailand
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.24.20139642
DO 10.1101/2020.06.24.20139642
A1 Wannarat A. Pongpirul
A1 Surasak Wiboonchutikul
A1 Lantharita Charoenpong
A1 Nayot Panitantum
A1 Apichart Vachiraphan
A1 Sumonmal Uttayamakul
A1 Krit Pongpirul
A1 Weerawat Manosuthi
A1 Wisit Prasithsirikul
YR 2020
UL http://medrxiv.org/content/early/2020/09/16/2020.06.24.20139642.abstract
AB Background Clinical spectrum of Coronavirus Disease 2019 (COVID-19) remains unclear, especially with regard to the presence of pneumonia. We aimed to describe the clinical course and final outcomes of adult patients with laboratory-confirmed COVID-19 in the full spectrum of disease severity. We also aimed to identify potential predictive factors for COVID-19 pneumonia.Methods and findings We conducted a retrospective study among adult patients with laboratory-confirmed COVID-19 who were hospitalized at Bamrasnaradura Infectious Diseases Institute, Thailand, between January 8 and April 16, 2020. One-hundred-and-ninety-three patients were included. The median (IQR) age was 37.0 (29.0-53.0) years, and 58.5% were male. More than half (56%) of the patients were mild disease severity, 22% were moderate, 14% were severe, and 3% were critical. Asymptomatic infection was found in 5%. The final clinical outcomes in 189 (97.9%) were recovered and 4 (2.1%) were deceased. The incidence of pneumonia was 39%. In multivariable logistic regression, increasing age (OR 2.55 per 10-year increase from 30 years old; 95% CI, 1.67-3.90; p<0.001), obesity (OR 8.74; 95%CI, 2.06-37.18; p=0.003), and higher temperature at presentation (OR 4.59 per 1°C increase from 37.2 °C; 95% CI, 2.30-9.17; p<0.001) were potential predictive factors for COVID-19 pneumonia.Conclusion Across the spectrum of disease severities, most patients with COVID-19 in our cohort had good final clinical outcomes. COVID-19 pneumonia was found in one-third of them. Older age, obesity, and higher fever at presentation were independent predictors of COVID-19 pneumonia.Author summary This report describes the clinical course and final clinical outcomes of the full spectrum of disease severity of Coronavirus Disease 2019 (COVID-19) and evaluates risk factors of pneumonia in 193 laboratory-confirmed cases of COVID-19 in the Bamrasnaradura Infectious Diseases Institute, Thailand. The majority of patients with COVID-19 had mild disease. COVID-19 pneumonia was found in approximately 40% of patients. Older age, obesity, and higher grade of fever at presentation were independent risk factors of pneumonia in adult patients with COVID-19. Most patients in our cohort recovered and were discharged from hospital (recovery rate, 98%). Our findings can help the public health systems to estimate the burden of the disease and identify vulnerable patients in a timely manner.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed and approved by the Bamrasnaradura Infectious Diseases Institute Institutional Review Board (S012h_63_ExPD).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript